Longwood Pharmaceuticals (hangzhou) Co., Ltd.

This is the first human study testing a new oral medication called LWP779, which is being developed to treat ischemic stroke. Researchers are giving the drug to 76 healthy volunteers to check if it's safe, how the body processes it, and what side effects might occur. The study wi…